INAMI in Belgium has published the list of hospitals that meet the criteria for reimbursement of certain implants and invasive medical devices

24

Apr 2017

In Belgium, number of procedures and devices can only be reimbursed for the hospitals, that meet certain requirements. INAMI has released a new lists of hospitals eligible for reimbursement for a number of procedures and devices in cardiovascular, neuromodulation, urology and orthopedics areas.

The following technologies are covered:

  • Neurosurgery (treatment of Parkinson's disease and essential tremors, refractory epilepsy and services relating to neurostimulation in the event of abnormal movements);
  • Urology and Nephrology (lower urinary tract dysfunction);
  • Abdominal Surgery and Digestive Pathology (catheters for radiofrequency ablation of dysplasia of a Barrett's esophagus);
  • Thoracic Surgery and Cardiology (implantable cardiac pacemakers and resynchronization pacemakers, their electrodes and implantable accessories, services relating to coronary stents and coronary dilatation, percutaneous repair of the mitral valve leaflet coaptation for the treatment of mitral valve regurgitation, ventricular assistance, TAVY system and accessories, percutaneous closure of the left auricle in the case of non-valvular atrial fibrillation);
  • Vascular Surgery (abdominal aortic stents and abdominal and thoracic, windowed and multi- branched stents);
  • Orthopedics and Traumatology (services relating to implants for the anchorage of an external prosthesis).

The list can be accessed here

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more